Medical Services International Inc. Agrees to Major Test of its VScan Rapid HIV Test Kit in Africa

Medical Services International Inc. Agrees to Major Test of its VScan Rapid HIV Test Kit in Africa

Business Wire - November 21, 2002

EDMONTON, Alberta--(BUSINESS WIRE)--Nov. 21, 2002--Medical Services International Inc. (Pink Sheets: MSITF) is pleased to announce that it has agreed with the regulatory authorities of a West African Nation to a study involving 200 VScan(TM) Rapid HIV Test Kits. The study is to start in 60 days with results in 90 days. Based on the anticipated results of the study, the Company will receive registration of its product in that country and the results can be used for registration in other surrounding countries in Africa.

Robert Talbot states, "We are extremely confident that the results will be as good as they were in Nigeria (see Press Release of November 19, 2002). This will open additional markets to Medical Services International Inc. in Africa."

About Medical Services International Inc.

Medical Services International Inc. is a medically related holding company with its head office in Edmonton, Canada. The diagnostic test division was created in response to a worldwide demand for less costly, rapid, technically simplified test methods to test for infectious diseases.

The Company has developed its VScan(TM) Rapid Test Kits for the detection of HIV 1 & 2, Hepatitis B & C and Tuberculosis. The Company is currently in negotiations with major healthcare concerns to supply these tests to the worldwide market. The test kits cannot be sold in Canada.

Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF."

Note: Certain statements in this news release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include, but are not limited to, new economic conditions, risk in product technology developments, market acceptance of new products and continuing product demand, level of competition and other factors described in the company reports, prospectus and other filings with the Securities and Exchange Commission.

CONTACT: Medical Services International Inc.

Robert Talbot, 780/430-6363

Bill Whitehead, Jr., 416/822-5883

Corporate Website: www.MedicalServicesIntl.com

SOURCE: Medical Services International Inc.

021121
BW021113

Copyright © 2002 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .